Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting No phase listed Observational

Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy

ClinicalTrials.gov ID: NCT05112237

Public ClinicalTrials.gov record NCT05112237. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 6, 2026, 9:51 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective and Retrospective Registry and Biomarker Study to Evaluate the Natural History of Pediatric Patients With Cardiomyopathy Due to MYBPC3 Mutations

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study is to collect information on patients with cardiomyopathy (CM) due to mutations in the MYBPC3 gene, to evaluate their disease course, burden of illness, risk factors for this disease, and the quality of life (QoL). This study will also collect information on treatments, procedures and outcome in infants and children up to 18 yrs who have this mutation.

Study identification

NCT ID
NCT05112237
Recruitment status
Active, not recruiting
Study type
Observational
Phase
Not listed
Lead sponsor
Tenaya Therapeutics
Industry
Enrollment
200 participants

Conditions and interventions

Conditions

Interventions

Not listed

Eligibility (public fields only)

Age range
0 Years to 18 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2021
Primary completion
May 31, 2028
Completion
May 31, 2028
Last update posted
Sep 1, 2026

2021 – 2028

United States locations

U.S. sites
21
U.S. states
10
U.S. cities
20
Facility City State ZIP Site status
Arkansas Children's Hospital Little Rock Arkansas 72202
Children's Hospital Los Angeles Los Angeles California 90027
University of California Davis Health Sacramento California 95817
Rady Children's Hospital - San Diego San Diego California 92123
University of Colorado Hospital - Anschutz Medical Campus Aurora Colorado 80045
Nemours Alfred I. Dupont Hospital for Children Wilmington Delaware 19803
Joe DiMaggio Children's Hospital Hollywood Florida 33021
Children's Mercy Hospital Kansas Kansas City Missouri 64108
St. Louis Children's Hospital St Louis Missouri 63110
Cohen Children's Medical Center Lake Success New York 11042
Mount Sinai New York New York 10029
Columbia University Irving Medical Center New York New York 10032
Montefiore Medical Center, Albert Einstein College of Medicine The Bronx New York 10467
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229
Cleveland Clinic Main Campus Cleveland Ohio 44195
DDC Clinic Center for Special Needs Children Middlefield Ohio 44062
Cardiology Care for Children Lancaster Pennsylvania 17601
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104
University of Pittsburgh Medical Center - Children's Hospital of Pittsburgh Pittsburgh Pennsylvania 15224
Children's Medical Center Dallas Dallas Texas 75207
Texas Children's Hospital Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05112237, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 1, 2026 · Synced Sep 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05112237 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →